{
    "pmcid": "7857409",
    "summary": "The paper \"An ultrapotent synthetic nanobody neutralizes SARS-CoV-2 by stabilizing inactive Spike\" presents a detailed study on the development of nanobodies that target the SARS-CoV-2 Spike protein, offering insights into their potential as therapeutic agents. Here is a detailed summary focusing on the SARS-CoV-2 Spike protein and its implications for designing nanobody binders:\n\n### SARS-CoV-2 Spike Protein Overview\n\n1. **Structure and Function**: The Spike protein is a homotrimeric transmembrane glycoprotein responsible for viral entry into host cells. It consists of two main domains:\n   - **S1 Domain**: Contains the receptor-binding domain (RBD) that interacts with the host cell receptor angiotensin-converting enzyme 2 (ACE2).\n   - **S2 Domain**: Facilitates the fusion of viral and host cell membranes.\n\n2. **Conformational States**: The RBD can exist in two states:\n   - **Up State**: Accessible for ACE2 binding, necessary for viral entry.\n   - **Down State**: Inaccessible, preventing ACE2 interaction.\n\n3. **Conformational Dynamics**: The Spike protein alternates between active (open) and inactive (closed) conformations, with the RBDs in the up and down states, respectively.\n\n### Nanobody Design and Screening\n\n1. **Library Screening**: A yeast surface-displayed library of synthetic nanobody sequences was screened to identify binders to the Spike ectodomain. A stabilized mutant form of Spike (SpikeS2P) was used as the antigen.\n\n2. **Nanobody Classes**:\n   - **Class I Nanobodies**: Bind directly to the RBD, blocking ACE2 interaction. Nb6 is a prototypical example with high affinity for SpikeS2P.\n   - **Class II Nanobodies**: Bind to other epitopes on Spike, not directly competing with ACE2 binding. Nb3 is a representative of this class.\n\n3. **Binding Characteristics**: Class I nanobodies showed faster association rates with the isolated RBD compared to SpikeS2P, indicating RBD accessibility influences binding affinity.\n\n### Structural Insights and Engineering\n\n1. **Cryo-EM Analysis**: Structures of Nb6 and Nb11 bound to SpikeS2P revealed that these nanobodies stabilize the RBDs in the down state, preventing ACE2 binding.\n   - **Nb6**: Straddles the interface between two adjacent RBDs, stabilizing the closed conformation.\n   - **Nb11**: Contacts a single RBD, also stabilizing the down state.\n\n2. **Multivalent Constructs**: Engineering of bivalent and trivalent nanobodies (e.g., Nb6-tri) showed enhanced binding affinity and neutralization potency due to avidity effects.\n\n3. **Affinity Maturation**: Mutations in Nb6 (e.g., I27Y and P105Y) led to mNb6 with significantly increased affinity and neutralization potency.\n\n### Neutralization Mechanism and Potency\n\n1. **Mechanism of Action**: Nanobodies neutralize SARS-CoV-2 by:\n   - Directly blocking ACE2 binding.\n   - Locking the Spike protein in an inactive conformation.\n\n2. **Potency**: Trivalent constructs like mNb6-tri demonstrated femtomolar affinity and picomolar neutralization potency against SARS-CoV-2, both in pseudovirus and live virus assays.\n\n3. **Stability and Delivery**: mNb6-tri retained function after aerosolization, lyophilization, and heat treatment, supporting its potential for direct airway delivery.\n\n### Implications for Therapeutic Development\n\n1. **Production and Delivery**: Nanobodies can be produced in bacteria or yeast, offering cost-effective and scalable production. Their stability allows for potential aerosol delivery, bypassing the need for intravenous administration.\n\n2. **Combination Therapies**: The study suggests combining class I and class II nanobodies could enhance therapeutic efficacy and prevent escape variants.\n\n3. **Future Directions**: The findings highlight the potential of nanobodies as a versatile and potent therapeutic strategy against SARS-CoV-2, with implications for addressing current and future coronavirus outbreaks.\n\nIn summary, the study provides a comprehensive framework for designing nanobody binders targeting the SARS-CoV-2 Spike protein, emphasizing the importance of stabilizing the protein in its inactive conformation to achieve potent neutralization.",
    "title": "An ultrapotent synthetic nanobody neutralizes SARS-CoV-2 by stabilizing inactive Spike"
}